Repositorio
Cómo publicar
Recursos
FAQs

Mostrar el registro sencillo del ítem

Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder

dc.contributor.authorKasper, Siegfried
dc.contributor.authorIglesias García, Celso Ángel 
dc.contributor.authorSchweizer, Edward
dc.contributor.authorWilson, Jacquelyn
dc.contributor.authorDuBrava, Sarah
dc.contributor.authorPrieto, Rita
dc.contributor.authorPitman, Verne W.
dc.contributor.authorKnapp, Lloyd
dc.date.accessioned2014-05-20T08:55:42Z
dc.date.available2014-05-20T08:55:42Z
dc.date.issued2014
dc.identifier.citationInternational Journal of Neuropsychopharmacology, 17(5), p. 685-695 (2014); doi:10.1017/S1461145713001557
dc.identifier.issn1461-1457
dc.identifier.issn1469-5111
dc.identifier.urihttp://hdl.handle.net/10651/26826
dc.description.sponsorshipThis study was funded by Pfizer Inc. Editorial support to prepare this manuscript for submission was provided by Lorna Forse, PhD, of Engage Scientific Solutions and funded by Pfizer Inc
dc.format.extentp. 685-695
dc.language.isoeng
dc.relation.ispartofInternational Journal of Neuropsychopharmacology
dc.rights© 2015 Collegium Internationale Neuro-Psychopharmacologicum
dc.rightsCC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceWOS:000333562300001
dc.titlePregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder
dc.typejournal article
dc.identifier.local20141646
dc.identifier.doi10.1017/S1461145713001557
dc.relation.publisherversionhttp://dx.doi.org/10.1017/S1461145713001557
dc.rights.accessRightsopen access


Ficheros en el ítem

untranslated
Nombre:
685.full.pdf
Tamaño:
253.4Kb
Formato:
PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2015 Collegium Internationale Neuro-Psychopharmacologicum
Este ítem está sujeto a una licencia Creative Commons